JIA subgroup | Mean total cost (SD) (median) | Mean indirect costs (SD) (median) | ||
---|---|---|---|---|
Whole group | Patients not in remission | Whole group | Patients not in remission | |
RF+, rheumatic factor seropositive; RF−, rheumatic factor seronegative; ERA, enthesitis-related arthritis. | ||||
Systemic arthritis | 10948 (15108) (1447) | 13334 (15134) (7135) | 8024 (13861) (0) | 9031 (14449) (311) |
Oligoarthritis | ||||
Persistent | 348 (887) (0) | 669 (1277) (0) | 403 (2245) (0) | 267 (706) (0) |
Extended | 16557 (25367) (1300) | 18627 (26293) (1777) | 12185 (18842) (0) | 13708 (18835) (623) |
Polyarthritis | ||||
RF+ | 25744 (26605) (25744) | 25744 (26605) (25744) | 18663 (21611) (18663) | 18663 (21611) (18663) |
RF− | 3411 (9408) (328) | 6458 (13126) (432) | 2777 (9233) (0) | 5553 (13002) (0) |
Psoriatic arthritis | 2832 (4642) (307) | 4248 (5574) (4248) | 1661 (2878) (0) | 2492 (3524) (2492) |
ERA | 1470 (3132) (46) | 2078 (3663) (133) | 320 (833) (0) | 469 (983) (0) |
Other arthritis | 944 (2928) (64) | 1560 (3797) (72) | 239 (999) (0) | 413 (1311) (0) |
All patients | 4298 (11449) (124) | 6906 (14066) (655) | 2910 (9043) (0) | 4593 (11075) (0) |